W Bounds

Medical-eligibility criteria for contraceptive use

Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure

Contraceptive failure in the United States

Blood pressure in women using oral contraceptives

Glioblastoma and Other Malignant Gliomas

Stopping oral contraceptives: an effective blood pressure-lowering intervention in women with hypertension

Influence of smoking and oral contraceptives on bone mineral density and bone remodeling in young women: a 2-year study

Interventions for emergency contraception

Clinically relevant drug interactions with antiepileptic drugs

Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline

2007 Guidelines for the Management of Arterial Hypertension

Human papillomavirus testing in primary cervical screening

The causal relation between human papillomavirus and cervical cancer

Contraception

A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins

Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Guidelines for management of hypertension: report of the third working party of the British Hypertension Society

Physiology of Local Renin-Angiotensin Systems

Hormones and pregnancy: thromboembolic risks for women

The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience

Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy

Polycystic ovary syndrome

Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle

Oral contraceptive tablets containing 20 and 30 μg of ethinyl estradiol with 150 μg desogestrel: Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone

epic3: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England

Mopping up hospital infection

Sexually Transmitted Infections Treatment Guidelines, 2021

Sexually Transmitted Diseases Treatment Guidelines, 2010

Aggregation-Induced Emission: Together We Shine, United We Soar!

Guidelines for the Primary Prevention of Stroke

Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).

U.S. Medical Eligibility Criteria for Contraceptive Use, 2016

Types of progestogens in combined oral contraception: effectiveness and side-effects

Interventions for emergency contraception

Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline

Venous Thrombosis and Changes of Hemostatic Variables during Cross-Sex Hormone Treatment in Transsexual People

Contraceptive Failure in the United States: A Critical Review of the Literature

The APTT Response of Pregnant Plasma to Unfractionated Heparin

Comparative In Vitro Sensitivities of Human Immune Cell Lines, Vaginal and Cervical Epithelial Cell Lines, and Primary Cells to Candidate Microbicides Nonoxynol 9, C31G, and Sodium Dodecyl Sulfate

Industry sponsorship and research outcome

Effect of Oral Contraceptives on Haemostasis Variables

Interventions for emergency contraception

Female condoms

Protein S levels are lower in women receiving desogestrel‐containing combined oral contraceptives (COCs) than in women receiving levonorgestrel‐containing COCs at steady state and on cross‐over

Randomised controlled trial assessing the acceptability of GyneFix® versus Gyne-T380S® for emergency contraception

Effect of four combined oral contraceptives on blood pressure in the pill-free interval

Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring

Observational series on women using the contraceptive Mirena® concurrently with anti-epileptic and other enzyme-inducing drugs

Changes in metabolism induced by oral contraceptives containing desogestrel and gestodene in older women

A possible mechanism of action of danazol and an ethinylestradiol/ norgestrel combination used as postcoital contraceptive agents

Side effects of danazol compared with an ethinyloestradiol/norgestrel combination when used for postcoital contraception

Comparison of four cytologic sampling techniques in a large family planning center.

Bone density in a population of long term oral contraceptive pill users does not differ from that in menstruating women.

A RANDOMIZED DOUBLE‐BLIND TRIAL OF TWO LOW DOSE COMBINED ORAL CONTRACEPTIVES

Progestogen-only oral contraception and ectopic gestation.

Changes in haemostasis after stopping the combined contraceptive pill: implications for major surgery.